Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

COVID-19 in newborns: could it alter key hormone pathways?

NCT ID NCT04952870

First seen May 29, 2026 · Last updated Jun 20, 2026 · Updated 4 times

Summary

This study follows 180 infants who had COVID-19 around birth to see if the infection affects hormone levels and development. Researchers focus on a temporary hormone surge called minipuberty, which is important for growth. By measuring hormones and developmental milestones, they hope to understand long-term effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEURODEVELOPMENTAL DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hop Jeanne de Flandre Chu Lille

    RECRUITING

    Lille, 59037, France

    Contact Phone: •••-•••-••••

  • Uri-National and Kapodistrian University of Athens

    NOT_YET_RECRUITING

    Athens, Greece

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could reveal how COVID-19 around birth affects infant development, pointing to ways to monitor or support at-risk children.

What could go wrong

This is an observational study, not a treatment trial. It is exploratory and may not find clear links. Results may not apply to all infants.

Conditions

The condition(s) this trial relates to.

disease neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.